Stock listing

TPEx:4168 GlycoNex, Inc. (醣聯) 股價

Follow GlycoNex, Inc. into a list and get an email when it puts out news.

Share price · TPEX:4168

$17.55 TWD -1.65 (-8.6%)

Close on Nov 20, 2026

Past year -18.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$17.55 – $18.70 TWDNov 20, 2026
Volume
238,489 sharesNov 20, 2026
Market cap
$1.97B TWDAt the close on Nov 20, 2026 · price × 112.5M shares outstanding
52-week range
$17.55 – $30.00 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2.08M TWDMedian day 87,065 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
GlycoNex, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:4168 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$17.55-1.65-8.6%$18.00$18.70$17.55238,489
$19.20-0.50-2.5%$20.00$20.00$19.00134,110
$19.70+0.20+1.0%$19.50$20.05$19.05169,819
$19.50-0.80-3.9%$20.30$20.65$19.30169,639
$20.300.000.0%$20.05$20.35$19.9089,410
$20.30-0.60-2.9%$20.90$20.90$19.75266,144
$20.90-0.25-1.2%$20.50$20.95$20.5050,572
$21.15+0.15+0.7%$21.10$21.45$20.7589,036
$21.00+1.05+5.3%$19.95$21.30$19.95160,297
$19.95-0.35-1.7%$18.30$19.95$18.30189,404
$20.30-0.45-2.2%$20.55$20.85$20.00111,036
$20.75-0.25-1.2%$21.00$21.00$20.0087,703
$21.00-0.25-1.2%$21.25$21.25$20.40125,153
$21.25-0.05-0.2%$21.00$21.30$20.9052,313
$21.30-0.15-0.7%$21.30$21.30$20.90142,273
$21.45-0.05-0.2%$21.50$21.80$21.2548,702
$21.500.000.0%$21.50$21.50$21.3062,366
$21.50+0.05+0.2%$21.30$22.05$21.0586,427
$21.450.000.0%$21.45$21.45$21.450
$21.45-0.30-1.4%$21.60$21.65$21.4073,144
$21.75+0.05+0.2%$21.70$21.85$21.6526,151
$21.70+0.10+0.5%$21.60$21.85$21.5570,117
$21.60-0.20-0.9%$22.35$22.35$21.5545,930
$21.80+0.10+0.5%$21.70$21.90$21.6054,179
$21.70-0.25-1.1%$21.80$21.80$21.5580,000
$21.95-0.15-0.7%$21.75$22.00$21.7572,001
$22.10-0.60-2.6%$22.60$22.60$21.80128,001
$22.70-0.10-0.4%$22.60$23.05$22.2595,000
$22.80-0.20-0.9%$23.00$23.00$22.6544,000
$23.00+0.25+1.1%$22.70$23.05$22.70128,158
$22.75-0.05-0.2%$22.70$22.75$22.5080,000
$22.80+0.40+1.8%$22.50$23.55$22.50167,013
$22.40+0.25+1.1%$22.55$23.00$22.25197,766
$22.15-0.20-0.9%$22.65$22.65$22.1082,005
$22.35+0.65+3.0%$21.70$22.40$21.60188,333
$21.70-0.25-1.1%$21.95$21.95$21.6535,000
$21.95+0.50+2.3%$21.30$22.15$21.30102,001
$21.45-0.15-0.7%$21.60$21.60$21.3575,000
$21.60-0.20-0.9%$21.80$21.80$21.40132,001
$21.80-0.15-0.7%$21.95$21.95$21.7537,496
$21.95+0.15+0.7%$21.80$22.00$21.50108,000
$21.80+0.25+1.2%$21.55$21.80$21.40178,400
$21.55-0.05-0.2%$21.50$21.60$21.4554,072
$21.60-0.20-0.9%$21.50$21.90$21.5048,000
$21.800.000.0%$21.60$21.80$21.0538,003
$21.80+0.20+0.9%$21.70$22.30$21.7092,000
$21.600.000.0%$21.50$21.60$21.30108,001
$21.60-0.25-1.1%$21.85$21.85$21.5074,000
$21.85-0.30-1.4%$22.00$22.00$21.50105,455
$22.15+0.05+0.2%$21.95$22.15$21.7596,100
$22.10-0.20-0.9%$22.00$22.35$21.90146,250
$22.30+0.05+0.2%$22.50$22.50$22.0578,001
$22.25-0.20-0.9%$22.20$22.45$21.9067,002
$22.45-0.10-0.4%$22.55$22.55$22.2588,000
$22.55-0.05-0.2%$22.40$22.55$22.2534,003
$22.60-0.15-0.7%$22.80$22.80$22.5543,000
$22.750.000.0%$22.50$22.80$22.4082,000
$22.75+0.05+0.2%$22.85$22.85$22.3090,002
$22.70+0.10+0.4%$22.60$22.80$22.3078,202
$22.600.000.0%$22.65$22.65$22.3560,178
$22.600.000.0%$22.60$22.80$22.2571,500
$22.60+0.10+0.4%$22.80$22.80$22.1590,001
Ticker
TPEx:4168
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TPEx
Currency
TWD

What changed lately

Latest news

All GlycoNex, Inc. news

GlycoNex, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
5 in the last 12 months · 8 in all · newest Aug 3, 2026 · oldest 2025
Decks
1 deck · latest Sep 17, 2026

Valuation

EV/sales 84.9× against a median of 4.6×: the highest of 9 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$1.89B TWD
P/E
Loss
EV/sales
84.9×
EV/EBITDA
Negative EBITDA
Price/book
2.3×
Gross margin
41.2%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.6×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
GlycoNex, Inc. · TPEX:4168US$59.92MUS$57.21Mn/a84.9×n/a2.3×n/a0.6×n/a
Poolbeg Pharma PLC · LSE:POLBUS$61.48MUS$55.17Mn/an/an/a7.0×n/a0.0×n/a
Oncopeptides AB · OMXSTO:ONCOUS$61.34MUS$59.14Mn/a6.3×n/a25.1×−223.6%5.4×n/a
vTv Therapeutics Inc. · NASDAQ:VTVTUS$61.33M−US$15.84Mn/a−0.4×n/a0.9×−20.8%0.0×1.28
ViGenCell, Inc. · KRX:308080US$61.08MUS$44.62Mn/a65.1×n/a2.1×n/a0.2×n/a
HemoGenyx Pharmaceuticals PLC · LSE:HEMOUS$60.51MUS$56.94Mn/an/an/a10.7×n/a0.4×n/a
Genexine, Inc. · KRX:095700US$60.02MUS$44.22Mn/a12.0×n/a0.4×−650.0%0.0×n/a
ISU Abxis Co., Ltd. · KRX:086890US$59.85MUS$42.29Mn/a1.1×n/a0.7×−16.0%0.0×n/a
Rani Therapeutics Holdings, Inc. · NASDAQ:RANIUS$58.99MUS$16.85Mn/a2.6×n/a1.7×−493.0%0.1×2.21
HeXun Biosciences Co Ltd · TPEX:6986US$57.20MUS$32.05M16.2×3.4×6.5×1.8×37.7%0.0×n/a
iNtRON Biotechnology, Inc. · KRX:048530US$57.04MUS$31.19Mn/a5.8×n/a1.2×−142.6%0.0×n/a
Median of the othersUS$60.27MUS$43.25M16.2×4.6×6.5×1.8×−142.6%0.0×1.75

Team and board

Officers

OfficerRole
Mei-Chun YangPresident & CEO
Ti-Fen WuChief Financial Officer
Tong-Hsuan ChangFounder & Chairman

Board

DirectorRole
Tong-Hsuan ChangFounder & Chairman

Events

QuarterResultsShare move
Q1 2023May 31, 2023+0.7%
Q4 2022Mar 1, 2023−1.9%
Q3 2022Nov 30, 2022+7.9%
Q2 2022Aug 31, 2022+18.0%
Q1 2022Jun 1, 20220.0%
Q4 2021Mar 2, 2022−0.5%
Q3 2021Dec 1, 2021−6.0%
Quarter to Jun 30, 2021Sep 1, 2021+0.9%
Quarter to Mar 31, 2021Jun 2, 2021−5.9%
Quarter to Dec 31, 2020Mar 3, 2021−0.4%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2026)Investor deck23 slidesSep 17, 2026

Open Decks

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue37.9M14.7M2.54M30.1M5.47M451.0K734.0K926.0K634.0K
Cost of revenue14.3M7.38M1.55M16.1M2.01M326.0K585.0K448.0K339.0K
Gross profit23.5M7.32M995.0K14.0M3.46M125.0K149.0K478.0K295.0K
Research and development222.4M204.6M210.4M197.4M145.0M157.0M218.9M269.6M111.7M
Selling, general and administrative50.9M48.9M45.3M50.8M48.9M52.5M51.1M52.4M49.4M
Operating income-249.8M-246.1M-158.0M-215.2M-172.5M-158.9M-269.9M-321.6M-160.8M
Depreciation and amortization35.4M34.4M31.2M40.0M40.1M46.6M54.1M55.8M52.3M
EBITDA-214.4M-211.7M-126.8M-175.2M-132.4M-112.3M-215.8M-265.8M-108.5M
Interest expense7.04M5.71M5.71M4.36M182.0K2.48M5.00K5.00K0
Income before tax-234.1M-229.7M-163.7M-219.8M-172.5M-161.4M-246.7M-317.6M-144.1M
Income tax14.6M1.32M549.0K-653.0K461.0K
Net income-235.2M-229.7M-178.4M-219.8M-172.5M-162.7M-247.2M-316.9M-144.6M
Earnings per share, basic-2.09-2.12-1.65-2.21-1.78-1.82-3.26-4.18-1.91

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents467.7M109.5M149.5M82.2M125.1M152.7M118.7M256.2M442.9M
Short-term investments225.6M332.6M550.3M596.6M206.5M326.2M61.7M91.3M138.1M
Receivables2.23M025.0K46.0K350.0K16.0K3.43M451.0K880.0K
Current assets748.1M481.2M718.3M713.1M358.7M499.2M186.4M360.8M595.7M
Property, plant and equipment989.9M1.02B1.05B1.09B1.13B1.17B
Total assets1.55B1.32B1.55B1.72B1.40B1.57B1.33B1.56B1.87B
Accounts payable900.0K900.0K900.0K2.20M2.73M2.13M
Current liabilities93.5M264.6M270.6M44.5M27.2M25.6M21.5M19.8M16.9M
Long-term debt473.6M00218.7M00
Total debt900.0K224.6M900.0K900.0K
Total liabilities571.9M270.0M276.4M271.3M36.1M34.5M31.4M29.4M25.2M
Shareholders' equity982.3M1.05B1.28B1.45B1.36B1.54B1.30B1.53B1.84B
Shares outstanding112.5M108.5M107.8M99.5M96.9M89.4M75.9M75.7M75.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-166.3M-222.0M-183.9M-167.5M-140.9M-145.6M-179.6M-180.3M61.4M
Capital spending-6.58M-35.3M-23.4M-8.69M-6.84M-1.87M-1.50M-3.22M-235.6M
Free cash flow-172.9M-257.2M-207.3M-176.2M-147.7M-147.5M-180.8M-183.6M-192.6M
Cash from investing-399.6M113.2M-199.7M28.0M-7.54M-252.5M
Cash from financing-6.72M524.2M-27.0K379.3M14.1M1.12M2.98M
Share buybacks0
Change in cash358.2M-40.0M67.3M-42.9M-27.7M34.0M-137.4M-186.8M-188.1M

Open Financials

Cap table

Built by 6ix from GlycoNex, Inc.’s releases

Common shares
112,521,000
Fully diluted
112,521,000

Fully diluted

LineShares
Common shares112,521,000

Share count over time

CountShares
Nov 22, 2026112,521,000

Open Cap table

Shareholders

Register

HolderSharesOf the companyChangeAs of
張東玄4.31M3.8%No changeOct 31, 2026
台灣尖端先進生技醫藥股份有限公司3.2M2.8%No changeOct 31, 2026
蘇秀娥2.16M1.9%No changeOct 31, 2026
楊玫君669K0.59%No changeOct 31, 2026
蘇文龍292K0.26%No changeOct 31, 2026
劉亮吟210K0.19%No changeOct 31, 2026
吳蒂芬188K0.17%No changeOct 31, 2026
呂耀華2,164<0.01%No changeOct 31, 2026
林炯森00.00%NewOct 31, 2026
許光陽00.00%NewOct 31, 2026
All 11 holders
HolderSharesOf the companyChangeAs of
蔡玲君00.00%NewOct 31, 2026

Funds

HolderSharesValueChangeAs of
Emerging Markets Core Equity 2 Portfolio341KUS$235KNo changeJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF53,745US$37,001+12,000Jul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF51,927US$35,749No changeJul 31, 2026
Emerging Markets Social Core Equity Portfolio37,545US$25,930+37,000Jul 31, 2026
The Emerging Markets Small Cap Series35,000US$24,172NewJul 31, 2026
Emerging Markets ex China Core Equity Portfolio29,527US$20,392No changeJul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio14,254US$9,844No changeJul 31, 2026
World ex U.S. Core Equity Portfolio13,000US$8,978NewJul 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mei-Chun YangPresident & CEO · Since at least Aug 3, 2026
Ti-Fen WuChief Financial Officer · Since at least Nov 5, 2026
Tong-Hsuan ChangFounder & Chairman · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about GlycoNex, Inc.